31 Result(s)

Living Reference Work Entry In depth

Interleukin-12/23 Inhibitors: Ustekinumab

Kevin D. Pile, Garry G Graham, Stephen M. Mahler in Encyclopedia of Inflammatory Diseases

Living Reference Work Entry In depth

Interleukin-6 Inhibitor – Tocilizumab

Kevin D. Pile, Garry G. Graham, Stephen M. Mahler in Encyclopedia of Inflammatory Diseases

Living Reference Work Entry In depth

Methotrexate

Kevin D. Pile, Garry G. Graham in Encyclopedia of Inflammatory Diseases

Living Reference Work Entry In depth

CD20 Inhibitors: Rituximab

Kevin D. Pile, Garry G. Graham, Stephen M. Mahler in Encyclopedia of Inflammatory Diseases

Living Reference Work Entry In depth

Phosphodiesterase 4 Inhibitors: Apremilast and Roflumilast

Garry G. Graham, Kevin D. Pile in Compendium of Inflammatory Diseases

Living Reference Work Entry In depth

Gold Complexes

Garry G. Graham, Kevin D. Pile in Encyclopedia of Inflammatory Diseases

Living Reference Work Entry In depth

Sulfasalazine and Related Drugs

Garry G. Graham, Kevin D. Pile in Encyclopedia of Inflammatory Diseases

Living Reference Work Entry In depth

Leflunomide

Kevin D. Pile, Garry G. Graham in Encyclopedia of Inflammatory Diseases

Living Reference Work Entry In depth

Tetracyclines

Garry G. Graham, Kevin D. Pile in Encyclopedia of Inflammatory Diseases

Chapter

C15 Disease-modifying antirheumatic drugs

RHEUMATOID ARTHRITIS (RA) is the most common inflammatory rheumatic disease, with a prevalence of about 1%. Targeting the synovial membrane, cartilage and bone, untreated RA leads to joint destruction, disabil...

Kevin D. Pile, Garry G. Graham, Stephen M. Mahler… in Principles of Immunopharmacology (2011)

Chapter

Disease-modifying anti-rheumatic drugs

Clarissa Bachmeier, Peter M. Brooks, Richard O. Day… in Principles of Immunopharmacology (2005)